| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |